Activation of the L-arginine nitric oxide pathway in severe sepsis

Archives of Disease in Childhood

Volumn 76, Issue 3, 1997, Pages 203-209

  Duke, Trevor ^a   South, Mike ^a   Stewart, Alastair ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

nitric oxide; nitrogen oxides; organ system failure; sepsis

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE; NITROGEN OXIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; INFANT; KIDNEY FUNCTION; MULTIPLE ORGAN FAILURE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURVIVAL; TISSUE PERFUSION;

EID: 0030888645     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.3.203     Document Type: Article

References (33)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
2. Preiser J-C, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med 1995;23:259-64.
3. Lorente JA, Landin L, Renes E, et al. Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 1993;21:759-67.
4. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994;28:34-9.
5. Daemen-Gubbels CRGH, Groenveld PHP, Groenveld ABJ, van Kamp GJ, Bronsveld W, Thijs LG. Methylene blue increases myocardial function in septic shock. Crit Care Med 1995;23:1363-70.
6. Hata JS, Dellinger RP. Nitric oxide inhibition in the treatment of septic shock. Crit Care Med 1995;23:1621-4.
7. Wong HR, Carcillo JA, Burchart G, Shah N, Janosky JE. Increased serum nitrite and nitrate concentrations in children with sepsis syndrome. Crit Care Med 1995;23:835-42.
8. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:621-6.
9. Shi Y, Li H-I, Shen C-K, et al. Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 1993;123:435-8.
10. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumour necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990;82:772-6.
11. Brady AJB, Poole-Wilson PA. Circulatory failure in septic shock. Nitric oxide: too much of a good thing? Br Heart J 1993;70:103-5.
12. Scabo CS, Mitchell JA, Thiemermann C. Nitric oxide mediated hyporeactivity to norepinephrine precedes nitric oxide synthase induction in endotoxin shock. Br J Pharmacol 1993;108:786-92.
13. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet J-C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259:H1038-43.
14. Friedman G, Berlot G, Kahn R, Vincent J-L. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995;23:1184-93.
15. Mackenzie IMJ, Young JD, Garrard CS. Serum nitrates as markers of postoperative morbidity. Lancet 1994;344:410.
16. Bone RC, Fisher CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317: 653-8.
17. Blumenthal S, Epps RP, Heavenrich R. Report on the taskforce on blood pressure control in children. Pediatrics 1977;59:802-3.
18. Jacobs RF, Sowell MK, Moss MM, Fiser DH. Septic shock in children: bacterial etiologies and temporal relationships. Pediatr Infect Dis J 1990;9:196-200.
19. Krafte-Jacobs B, Carver J, Wilkinson JD. Comparison of gastric intramucosal pH and standard perfusional measurements in pediatric septic shock. Chest 1995;108:220-5.
20. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
21. Andrew M, Paes B, Milner R. The development of the human coagulation system in the fullterm infant. Blood 1987;70:165-72.
22. Andrew M, Paes B, Milner R. Development of the coagulation system in the healthy premature infant. Blood 1988;72: 1651-7.
23. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1999;12:95-104.
24. Department of Clinical Biochemistry, Royal Children's Hospital. Reference ranges in clinical biochemistry. Melbourne: Educational Resources Centre, Royal Children's Hospital, 1993: 2-23.
25. Shann F. Drug doses. Melbourne: Collective Pty Ltd, 1996: 65.
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985;202: 685-93.
27. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 1991;17:S25-33.
28. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 1995;3:2-32.
29. De Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis 1995;21:S162-5.
30. Malawista SE, Montgomery RR, Van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. J Clin Invest 1992;90: 631-6.
31. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
32. Kanwar S, Kubes P. Nitric oxide is an antiadhesive molecule for leukocytes. New Horizons 1995;3:93-103.
33. Beckman JS, Beckman TW, Chen J. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.